Cargando…

New digital tool to facilitate subcutaneous insulin therapy orders: an inpatient insulin dose calculator

BACKGROUND: Inpatient hyperglycemia is associated with adverse outcomes in hospitalized patients, with or without known diabetes. The adherence to American College of Endocrinology and American Diabetes Association guidelines recommendations for inpatient glycemic control is still poor, probably bec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toyoshima, Marcos Tadashi Kakitani, de Souza, Alexandre Barbosa Câmara, Admoni, Sharon Nina, Cukier, Priscilla, Lottenberg, Simão Augusto, Latronico, Ana Claudia, Nery, Márcia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687348/ https://www.ncbi.nlm.nih.gov/pubmed/26697118 http://dx.doi.org/10.1186/s13098-015-0111-7

Ejemplares similares

Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
por: Toyoshima, Marcos Tadashi Kakitani, et al.
Publicado: (2022)

InsulinAPP application protocol for the inpatient management of type 2 diabetes on a hospitalist-managed ward: a retrospective study
por: Toyoshima, Marcos Tadashi Kakitani, et al.
Publicado: (2022)

Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)
por: Toyoshima, Marcos Tadashi Kakitani, et al.
Publicado: (2023)

Medical software applications for in-hospital insulin therapy: A systematic review
por: Jones, Julia Mandaro Lavinas, et al.
Publicado: (2020)

Lipodystrophy: Still an underdiagnosed complication of subcutaneous insulin administration
por: Barbosa, Mariana, et al.
Publicado: (2022)

Biodistribution of Insulin Following Massive Insulin Subcutaneous Injection
por: Ikeda, Tomoya, et al.
Publicado: (2022)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Challenges With Insulin in the Inpatient Setting
por: Kolanczyk, Denise M., et al.
Publicado: (2016)

Evidence-based clinical use of insulin premixtures
por: Tambascia, Marcos Antônio, et al.
Publicado: (2013)

Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection
por: Park, Eun-Joo, et al.
Publicado: (2008)

Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens
por: Tham, Lai San, et al.
Publicado: (2017)

Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
por: Ishii, Takahiro, et al.
Publicado: (2021)

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance
por: Nakamura, Yuko, et al.
Publicado: (2020)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Haemorrhagic shock induced by subcutaneous insulin injection
por: Kimura, Tomonori, et al.
Publicado: (2011)

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
por: Kapitza, Christoph, et al.
Publicado: (2010)

Role of Subcutaneous Adipose Tissue in the Pathogenesis of Insulin Resistance
por: Patel, Pavankumar, et al.
Publicado: (2013)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Integrative Analyses of Genes Associated with Subcutaneous Insulin Resistance
por: Pujar, Manoj Kumar, et al.
Publicado: (2019)

Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase
por: Morrow, Linda, et al.
Publicado: (2013)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients
por: Lim, Yejee, et al.
Publicado: (2022)

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes
por: GAO, GUAN-QI, et al.
Publicado: (2014)

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
por: Cui, Ling, et al.
Publicado: (2020)

Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion
por: Yamada, Eijiro, et al.
Publicado: (2017)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
por: Gradel, A. K. J., et al.
Publicado: (2018)

The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance
por: Alman, Amy C., et al.
Publicado: (2017)

Effectiveness of a Computerized Insulin Order Template in General Medical Inpatients With Type 2 Diabetes: A cluster randomized trial
por: Wexler, Deborah J., et al.
Publicado: (2010)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
por: Hauzenberger, Jasmin R., et al.
Publicado: (2017)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
por: Grant, Marshall, et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
por: Regittnig, Werner, et al.
Publicado: (2021)

Inpatient Glycaemic Control is Poor in Patients Receiving Insulin Therapy
por: Reidy, Niall, et al.
Publicado: (2021)

Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome
por: Jassam, N, et al.
Publicado: (2014)

Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
por: Nakamura, Tomoaki, et al.
Publicado: (2014)

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices
por: El-Laboudi, Ahmed H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8937ev69a9meanv5jhfev6e7gu